454 related articles for article (PubMed ID: 17694554)
1. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
Cristofanilli M; Valero V; Buzdar AU; Kau SW; Broglio KR; Gonzalez-Angulo AM; Sneige N; Islam R; Ueno NT; Buchholz TA; Singletary SE; Hortobagyi GN
Cancer; 2007 Oct; 110(7):1436-44. PubMed ID: 17694554
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of body mass index in locally advanced breast cancer.
Dawood S; Broglio K; Gonzalez-Angulo AM; Kau SW; Islam R; Hortobagyi GN; Cristofanilli M
Clin Cancer Res; 2008 Mar; 14(6):1718-25. PubMed ID: 18347172
[TBL] [Abstract][Full Text] [Related]
3. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer.
Asoglu O; Muslumanoglu M; Igci A; Ozmen V; Karanlik H; Ayalp K; Bozfakioglu Y; Kecer M; Parlak M
Acta Chir Belg; 2005 Feb; 105(1):62-8. PubMed ID: 15790205
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy.
Low JA; Berman AW; Steinberg SM; Danforth DN; Lippman ME; Swain SM
J Clin Oncol; 2004 Oct; 22(20):4067-74. PubMed ID: 15483018
[TBL] [Abstract][Full Text] [Related]
5. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
[TBL] [Abstract][Full Text] [Related]
6. A single-center experience with inflammatory breast cancer, 1985-2003.
Smoot RL; Koch CA; Degnim AC; Sterioff S; Donohue JH; Grant CS; Barnes SA; Gullerud RE; Hobday TJ; Farley DR
Arch Surg; 2006 Jun; 141(6):567-72; discussion 572-3. PubMed ID: 16785357
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
Anderson WF; Chu KC; Chang S
J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
Gonzalez-Angulo AM; Cristofanilli M; Strom EA; Buzdar AU; Kau SW; Broglio KR; Smith TL; Hortobagyi GN
Cancer; 2004 Oct; 101(8):1760-6. PubMed ID: 15386311
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease.
Liauw SL; Benda RK; Morris CG; Mendenhall NP
Cancer; 2004 Mar; 100(5):920-8. PubMed ID: 14983486
[TBL] [Abstract][Full Text] [Related]
10. Intent of therapy in metastatic breast cancer with isolated ipsilateral supraclavicular lymph node spread--a therapeutic dilemma.
Deo SV; Purkayastha J; Shukla NK; Raina V; Asthana S; Das DK; Rath GK
J Assoc Physicians India; 2003 Mar; 51():272-5. PubMed ID: 12839350
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
Parikh RR; Housman D; Yang Q; Toppmeyer D; Wilson LD; Haffty BG
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1056-63. PubMed ID: 18676094
[TBL] [Abstract][Full Text] [Related]
12. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment.
Bertucci F; Tarpin C; Charafe-Jauffret E; Bardou VJ; Braud AC; Tallet A; Gravis G; Viret F; Gonçalves A; Houvenaeghel G; Blaise D; Jacquemier J; Maraninchi D; Viens P
Bone Marrow Transplant; 2004 May; 33(9):913-20. PubMed ID: 15004544
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of initial clinical disease stage after achieving pathological complete response.
Dawood S; Broglio K; Kau SW; Islam R; Symmans WF; Buchholz TA; McGuire SE; Meric-Bernstam F; Cristofanilli M; Hortobágyi GN; Gonzalez-Angulo AM
Oncologist; 2008 Jan; 13(1):6-15. PubMed ID: 18245008
[TBL] [Abstract][Full Text] [Related]
15. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation.
Abramowitz MC; Li T; Morrow M; Sigurdson ER; Anderson P; Nicolaou N; Freedman G
Am J Clin Oncol; 2009 Feb; 32(1):30-3. PubMed ID: 19194121
[TBL] [Abstract][Full Text] [Related]
16. Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
Somlo G; Frankel P; Chow W; Leong L; Margolin K; Morgan R; Shibata S; Chu P; Forman S; Lim D; Twardowski P; Weitzel J; Alvarnas J; Kogut N; Schriber J; Fermin E; Yen Y; Damon L; Doroshow JH
J Clin Oncol; 2004 May; 22(10):1839-48. PubMed ID: 15143076
[TBL] [Abstract][Full Text] [Related]
17. [Inflammatory breast cancer: 38 cases clinical report].
Huang J; Zhang P; Liu P; Ou GF; Wang ZP; Xu BH
Ai Zheng; 2002 Aug; 21(8):888-91. PubMed ID: 12478900
[TBL] [Abstract][Full Text] [Related]
18. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
19. Recurrence pattern and prognosis in low-risk breast cancer patients--data from the DBCG 89-A programme.
Christiansen P; Al-Suliman N; Bjerre K; Møller S;
Acta Oncol; 2008; 47(4):691-703. PubMed ID: 18465337
[TBL] [Abstract][Full Text] [Related]
20. Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.
Gonzalez-Angulo AM; McGuire SE; Buchholz TA; Tucker SL; Kuerer HM; Rouzier R; Kau SW; Huang EH; Morandi P; Ocana A; Cristofanilli M; Valero V; Buzdar AU; Hortobagyi GN
J Clin Oncol; 2005 Oct; 23(28):7098-104. PubMed ID: 16192593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
